PGS Sample Set (PSS): PSS000600

Phenotype CKDi25 cases defined as >25% eGFRcrea decline during follow-up together with a movement from eGFRcrea≥60 mL/min/1.73m^2 at baseline to eGFR<60 mL/min/1.73m^2 at follow up compared to CKDi25 controls defined as eGFRcrea≥60 mL/min/1.73m^2. High risk groups had 8-14 adverse alleles. Low risk groups had 0-5 adverse alleles.
Sample Ancestry European

Sample Numbers

Total number
11,440 individuals
Detailed numbers
448 cases (3.92%)
10,992 controls
Number of Cohort(s) 3
Sample distribution


Cohort Short Name Cohort Full Name Previous/other/additional names (e.g. sub-cohorts)
KORA Cooperative Health Research in the Region of Augsburg KORA F3, KORA F4, KORA S3, KORA S4
UKB UK Biobank

Additional information

87.61% overlap between the CKDi25 GWAS cohort and this dataset.